KIMBERLY ELMSHAEUSER: Open Payments
NPI 1710529029 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 54 payments from 16 companies in 2025. Trend: 2023 $681 · 2024 $1,407 · 2025 $2,142
Food & beverage: $2,142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $383 |
| AstraZeneca Pharmaceuticals LP | 10 | $333 |
| Lilly USA, LLC | 5 | $298 |
| Phathom Pharmaceuticals, Inc. | 11 | $233 |
| GENZYME CORPORATION | 2 | $223 |
| Novo Nordisk Inc | 5 | $141 |
| Dexcom, Inc. | 3 | $137 |
| Medtronic, Inc. | 1 | $117 |
| SANOFI-AVENTIS U.S. LLC | 3 | $96 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: VRAYLAR, VOQUEZNA, DUPIXENT, MOUNJARO, AIRSUPRA, Dexcom G6 Transmitter, QULIPTA, BREZTRI.
Industry payments across TX — which companies pay providers there.
